Replies to post #32376 on Revive Therapeutics Ltd (RVVTF)

[govprs]

Trading like it’s being shorted.

[Hattrick3]

Not sure why the write ups on VERU are so bullish. They were at or around 55% efficacy on 204 moderate to severe patients and that is with an extremely high death rate on the placebo side. They have the only trial I know of where hospitalized patients had a placebo death rate of 35%! We would have had an EUA done and in the books already with a death rate of half of that. That will be tough to explain to the FDA. A sample of 204 is crazy low for an EUA. It has to be nothing but great news for Bucillamine’s chances if the FDA let’s them through.

[rickstereo3333]

As you intimated, Veru's drug isnt playing in the same playpen as buc so what they do and how fast is not that relevant to us.

The era of covid shite trials aided and abetted by the fda has spoilt many in terms of accepting how slow and deliberate this process is supposed to be, hence the impatience.

At this point the original endpoints are less important when compared to the new ones sought, ie substantial symptom relief and recovery time.

Add to that buc being an effective treatment for long covid and this goes orbital.

Raw material suppliers (korea/japan) and manufacturers (india/usa) are in place, based on past pr's, so initial production demand should be covered imo.

If I recall, the india and/or us based manufacturers were touted as having the ability to scale up to 5 bil pills???

Also, mike not acting like the average prat ceo in pennyland that spews shite non stop is partly, albeit a small part, why im super bullish on rvv and keep adding weekly.

W'ell see soon enough if its going to be A5 Olive Wagyu or Carrion. lololsss